In real-world practice, several patients can all ask about the same medication and still need very different plans: One may have significant GI sensitivity and need slower escalation
Exclusion criteria included diagnosis of type 1 diabetes, pregnancy, use of any GLP-1 RA or DPP4i during the baseline period, use of 2 types of products in the index drug class on the index date, initiation of another new glucose-lowering drug class on the index date, bariatric surgery, or use of antiobesity medications during the study period
May reduce common opioid risks like dependence and sedation
The claims related to satiety signals and lipid metabolism are best interpreted as supportive rather than curative
The combination of CJC-1295 and Ipamorelin has garnered significant interest in peptide research due to its potential to enhance growth hormone axis signaling
Differences in outcomes were also observed between patients with GVHD who responded to treatment and those who did not, highlighting the influence of disease control on self-reported well-being